Hydatidiform Mole Pregnancy Trophoblast Extracts Differentially Suppress lnterleukin‐2‐lnduced Proliferation of Human T‐Lymphocytes and PHA‐Blasts
- 31 May 1990
- journal article
- research article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 23 (2) , 44-49
- https://doi.org/10.1111/j.1600-0897.1990.tb00669.x
Abstract
Immunoregulatory factors of trophoblast origin may partially abrogate maternal immune responses to the fetus during pregnancy. We have previously shown that soluble factors extracted from hydatidiform mole trophoblast suppress interleukin-2 (IL-2)-dependent proliferation of a cloned murine cytotoxic T cell line (CTLL-2). To characterize human T cell responses to this trophoblast extract, we measured the effects of molar tissue extracts (HME) on IL-2-stimulated proliferation of human T-lymphocytes and mitogen (PHA) transformed T-cell blasts (PHA-blasts). HME significantly (P < 0.05) suppressed T-lymphocyte proliferation in response to 5 and 10 units/ml of IL-2 at 500 and 250 .mu.g/ml, while no effect was observed at the 100 .mu.g/ml concentration. Suppression by HME of IL-2-stimulated T-cell proliferation was partially overcome by the addition of excess IL-2. HME also suppressed (P < 0.05) IL-2-stimulated proliferation of PHA-blasts at 500 and 250 .mu.g/well at both 5 and 10 units/ml of IL-2. As observed with resting T-cell responses, no suppression of PHA-blast proliferation was observed using 100 .mu.g/ml of HME. In contrast to the response of the resting T-cells to excess IL-2, HME suppression of IL-2-stimulated blast proliferation was not affected by increasing the concentration of IL-2. These results indicate that extracts from hydatidiform mole trophoblast contain immunosuppressive factors that block human T-cell clonal expansion by inhibiting the utilization and/or production of IL-2. Furthermore, the effects of HME are not reversed by excess IL-2 when PHA-blasts are reacted compared to resting T-cell responses, which are partially reversed in the presence of excess IL-2. This suggests that human trophoblast-derived immunoregulatory factors that are present in hydatidiform mole inhibit human lymphocyte utilization of IL-2 in a fashion similar to the murine (CTLL) model, and exhibit irreversible effects on lymphocytes containing high affinity IL-2 receptors (PHA-blasts) compared to lymphocytes with only low affinity IL-2 receptors (resting T-cell). This property of the trophoblast may partially explain how hydatidiform mole, and possibly pregnancy trophoblast in general, escapes lethal immunological challenge by the maternal immune system.Keywords
This publication has 25 references indexed in Scilit:
- Suppression of lymphocyte alloreactivity by early gestational human deciduaCellular Immunology, 1988
- Suppression of lymphocyte alloreactivity by early gestational human deciduaCellular Immunology, 1988
- Interleukin-2: Inception, Impact, and ImplicationsScience, 1988
- Antiviral activity of the pregnancy recognition hormone ovine trophoblast protein-1Biochemical and Biophysical Research Communications, 1988
- Suppression of Interleukin-2-Mediated T-Lymphocyte Blastogenesis by Ovine Uterine Luminal Protein1Biology of Reproduction, 1988
- Interferon-like sequence of ovine trophoblast protein secreted by embryonic trophectodermNature, 1987
- The interleukin 2 receptor. Functional consequences of its bimolecular structure.The Journal of Experimental Medicine, 1987
- Interleukin 2 high-affinity receptor expression requires two distinct binding proteins.The Journal of Experimental Medicine, 1987
- THE HISTOCOMPATIBILITY ANTIGENS OF FERTILIZED MOUSE EGGS AND TROPHOBLAST*Annals of the New York Academy of Sciences, 1966
- TRANSPLANTATION OF EGGS TO THE KIDNEY AND UTERUS OF IMMUNISED MICETransplantation, 1966